SCHEMBL21753172

SCHEMBL21753172

CN(C)S(=O)(=O)N1CCc2c(nc(Cl)nc2NCCc2c[nH]c3ccccc23)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ BRD4 O60885 1/20 0.41
▸ HRH3 Q9Y5N1 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ POLB P06746 2/20 0.40
▸ SLC2A1 P11166 1/20 0.40
▸ RAD52 P43351 1/20 0.40
▸ EIF2AK2 P19525 1/20 0.40
▸ CYP19A1 P11511 1/20 0.40
▸ ABCC1 P33527 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ GPR18 Q14330 2/20 0.39
▸ NSD2 O96028 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ GFER P55789 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21758301 0.91 USP2 (0.42) USP2ALOX15HRH3KMT2APOLB
SCHEMBL21758435 0.85 HTR1A (0.46) USP2ALOX15HRH3KMT2APOLB
SCHEMBL21758310 0.84 BCHE (0.42) USP2ALOX15HRH3KMT2AGPR18
SCHEMBL21758302 0.83 USP2 (0.44) USP2ALOX15HRH3KMT2APOLB
SCHEMBL21753194 0.83 GLA (0.48) USP2ALOX15HRH3KMT2APOLB
SCHEMBL21753163 0.82 GBA1 (0.44) USP2ALOX15BRD4KMT2AEIF2AK2
SCHEMBL31297717 0.82 GBA1 (0.44) USP2ALOX15BRD4KMT2AEIF2AK2
SCHEMBL25378084 0.82 CDK2 (0.45) USP2ALOX15HRH3KMT2APOLB
SCHEMBL21758438 0.81 BCHE (0.43) USP2ALOX15HRH3KMT2APOLB
SCHEMBL23928090 0.79 HTR1A (0.43) KMT2APOLBSLC2A1RAD52NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12221439-B2 Tetrahydropyridopyrimidine derivatives as AhR modulators JAGUAHR THERAPEUTICS PTE LTD (SG) 2025-02-11 — — US disclosed
EP-3841102-B1 TETRAHYDROPYRIDOPYRIMIDINE DERIVATIVES AS AHR MODULATORS JAGUAHR THERAPEUTICS PTE LTD (SG) 2022-09-14 — — EP disclosed
US-20210332041-A1 TETRAHYDROPYRIDOPYRIMIDINE DERIVATIVES AS AHR MODULATORS JAGUAHR THERAPEUTICS PTE LTD (SG) 2021-10-28 — — US disclosed
US-20210332041-A1 TETRAHYDROPYRIDOPYRIMIDINE DERIVATIVES AS AHR MODULATORS JAGUAHR THERAPEUTICS PTE LTD (SG) 2021-10-28 — — US disclosed
EP-3841102-A1 TETRAHYDROPYRIDOPYRIMIDINE DERIVATIVES AS AHR MODULATORS JAGUAHR THERAPEUTICS PTE LTD (SG) 2021-06-30 — — EP disclosed
WO-2020039093-A1 TETRAHYDROPYRIDOPYRIMIDINE DERIVATIVES AS AHR MODULATORS JAGUAHR THERAPEUTICS PTE LTD (SG) 2020-02-27 — — WO disclosed
WO-2020039093-A1 TETRAHYDROPYRIDOPYRIMIDINE DERIVATIVES AS AHR MODULATORS JAGUAHR THERAPEUTICS PTE LTD (SG) 2020-02-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210332041-A1 TETRAHYDROPYRIDOPYRIMIDINE DERIVATIVES AS AHR MODULATORS AHR, ARNT, NQO1 USP2 2372/4885ALOX15 485/4885BRD4 674/4885
US-12221439-B2 Tetrahydropyridopyrimidine derivatives as AhR modulators AHR, ARNT, NQO1 USP2 2372/4885ALOX15 485/4885BRD4 674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback